News
Stay Ahead with the Latest Industry Trends & Market Insights with Industry News 📰

Asia Pacific Digital Therapeutics Market Size, Share, and Outlook (2024-2031)

Published: November 2024 || SKU: HCIT7400
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
Get Free Sample

Get Expert Insights on Asia Pacific Digital Therapeutics Market

Talk to analysts

Asia Pacific Digital Therapeutics Market is segmented By Product Type (Software, Devices, Others), By Application (Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Diseases, Respiratory Diseases, Smoking Cessation, Gastrointestinal Disorders (GID), Others), By Sales Channel (Business-to-Business (B2B), Business-to-Consumer (B2C)), and By Country ( China, India, Japan, Australia) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031.

 

Market Overview

Asia Pacific Digital Therapeutics Market is expected to grow at a CAGR of 23.30% during the forecast period 2024-2031.

Digital therapeutics is a healthcare solution and treatment option that uses digital technologies to cure patients with medical or psychological problems. It offers a new approach to disease management by using high-quality software and systems to assist patients in monitoring their health conditions at home. These solutions use the internet infrastructure, smartphones, and advanced technologies such as artificial intelligence (AI), machine learning, and big data analytics to customize the treatment to the patient. 

The digital therapeutics market includes various products such as telemedicine platforms, apps, wearable devices, and others. Currently, there are many healthcare apps and wearable devices that are easily accessible worldwide.

Market Scope

MetricsDetails
CAGR23.30%
Size Available for Years2022-2031
Forecast Period2024-2031
Data AvailabilityValue (US$) 
Segments CoveredProduct Type, Application, Sales Channel, and Country
Countries CoveredChina, India, Japan, Australia 
Largest CountryJapan
Report Insights CoveredCompetitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.

 

For more details on this report - Request for Sample

 

Market Dynamics

The Increasing usage of smartphones & tablets

The Asia Pacific region is witnessing significant growth in the digital therapeutics market. This growth is primarily driven by the increasing usage of smartphones and tablets and a year-on-year rise in the incidence of chronic diseases. Technological advancements in mobile healthcare and improved drug compliance have further boosted the digital therapeutics market in this region. Additionally, there is a growing demand for PDTx due to their profitability. 

The Rise in ageing population suffering from chronic diseases is expected to contribute to this growth

The market for prescription digital therapeutics is expected to grow globally due to factors such as easy accessibility, patient comfort, and the potential to influence behavioural change. Additionally, the rise in aging population suffering from chronic diseases is expected to contribute to this growth. Moreover, government initiatives aimed at improving healthcare services and infrastructure in various regions around the world further encourage the growth of this market. 

Impact of COVID-19 on the Asia-Pacific digital therapeutics market

The COVID-19 outbreak has disrupted healthcare systems in APAC, leading to a focus on strengthening infrastructure. The pandemic has increased awareness of digital health, mental illness, and drug abuse, positively impacting the growth of the digital therapeutics market. The nationwide lockdown has resulted in unhealthy lifestyles and increased mental stress, leading to the demand for therapeutic devices and software.

Market Segment Analysis

The Asia Pacific Digital Therapeutics Market is segmented into product type, application, sales channel and country

By Product Type 

  • Software
  • Devices
  • Others

By Application 

  • Diabetes
  • Obesity
  • Cardiovascular Diseases (CVD)
  • Central Nervous System (CNS) Diseases
  • Respiratory Diseases
  • Smoking Cessation
  • Gastrointestinal Disorders (GID)
  • Others

By Sales Channel 

  • Business-to-Business (B2B)
    • Employer
    • Healthcare Providers
    • Payers
    • Pharmaceutical Companies
    • Others
  • Business-to-Consumer (B2C)
    • Patient
    • Caregiver

By Country

  • China
  • India
  • Japan
  • Australia

Market Geographical Share

The Asia Pacific Digital Therapeutics Market can be segmented into China, India, Japan, and Australia.

The Asia Pacific market is projected to have substantial growth over the forecast period from a geographical perspective. Within the Asia-Pacific (APAC) region, it is anticipated that the Chinese market will exhibit a robust growth rate from 2024 to 2031. The Indian market is expected to see substantial growth throughout the projected timeframe.  The Indian market is seeing an increase in its size due to the proliferation of hospital applications and the rising incidence of chronic illnesses.

The digital therapeutics market in Japan and Australia is projected to have significant growth over the forecast period, primarily due to the increasing use of tablets and smartphones.

Market Companies

Companies like Fitbit, Inc. (Twine Health, Inc.), Medtronic Plc., Novartis International AG (Pear Therapeutics, Inc.), Resmed, Inc. (Propeller Health), Voluntis, Inc., Ada Health GmbH, Cognifit ltd, Caterna Vision GmbH, Sonormed GmbH, and Kaia Health are playing a leading role in the APAC digital therapeutics market.

Why purchase Asia Pacific Digital Therapeutics Market report?

Technological Innovations

Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.

Product Performance & Market Positioning

Analyzes product performance, market positioning, and growth potential to optimize strategies.

Real-World Evidence

Integrates patient feedback and data into product development for improved outcomes.

Physician Preferences & Health System Impact

Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.

Market Updates & Industry Changes

Covers recent regulatory changes, new policies, and emerging technologies.

Competitive Strategies

Analyzes competitor strategies, market share, and emerging players.

Pricing & Market Access

Reviews pricing models, reimbursement trends, and market access strategies.

Market Entry & Expansion

Identifies optimal strategies for entering new markets and partnerships.

Regional Growth & Investment

Highlights high-growth regions and investment opportunities.

Supply Chain Optimization

Assesses supply chain risks and distribution strategies for efficient product delivery.

Sustainability & Regulatory Impact

Focuses on eco-friendly practices and evolving regulations in healthcare.

Post-market Surveillance

Uses post-market data to enhance product safety and access.

Pharmacoeconomics & Value-Based Pricing

Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

Target Audience 2025

Manufacturers

Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.

Regulatory & Policy

Compliance Officers, Government, Health Economists, Market Access Specialists.

Application & Innovation

AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.

Investors

Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.

Consulting & Advisory

Healthcare Consultants, Industry Associations, Analysts.

Supply Chain

Distribution and Supply Chain Managers.

Consumers & Advocacy

Patients, Advocacy Groups, Insurance Companies.

Academic & Research

Academic Institutions.

Buy this report
Single User
$3750
Multiple User
$4000
Enterprise User
$7250
Proceed to Buy
  Get Free Sample
  Customize Sample
  Demo Full Report
Chat on WhatsApp
FAQ’s

  • The Projected CAGR value is 23.30%.

  • Key players are Fitbit, Inc. (Twine Health, Inc.), Medtronic Plc., Novartis International AG (Pear Therapeutics, Inc.), Resmed, Inc. (Propeller Health), Voluntis, Inc., Ada Health GmbH, Cognifit ltd, Caterna Vision GmbH, Sonormed GmbH, and Kaia Health.

  • The segments are By Product Type, By Application, By Sales Channel, and By Country.

  • Japan is the Largest Market Share in Asia Pacific Digital Therapeutics Market.
Related Reports
healthcare-it iconhealthcare-it

Biological Safety Testing Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 17

Starting from

$4350

healthcare-it iconhealthcare-it

Nanobots Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 17

Starting from

$4350

healthcare-it iconhealthcare-it

Medical Display Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 17

Starting from

$4350

healthcare-it iconhealthcare-it

Software as a Medical Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 November 04

Starting from

$4350

healthcare-it iconhealthcare-it

Cardiology Information System Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 07

Starting from

$4350

healthcare-it iconhealthcare-it

Ambulatory EHR Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 November 20

Starting from

$4350

WhatsApp